Translating nociceptive processing into human pain models

Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M (2003) Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106:49–57 Bickel A, Dorfs S, Schmelz M, Forster C, Uhl W, Handwerker HO (1998) Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain 76:317–325 Bishop T, Hewson DW, Yip PK, Fahey MS, Dawbarn D, Young AR, McMahon SB (2007) Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat. Pain 131:70–82 Bishop T, Ballard A, Holmes H, Young AR, McMahon SB (2009) Ultraviolet-B induced inflammation of human skin: characterisation and comparison with traditional models of hyperlagesia. Eur J Pain 13:524–532 Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W (2004) Opioid-induced mast cell activation and vascular responses is not mediated by micro -opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg 98:364–370 Cervero F, Gilbert R, Hammond RGE, Tanner J (1993) Development of secondary hyperalgesia following nonpainful thermal stimulation of the skin a psychophysical study in man. Pain 54:181–189 Chapman LF, Dingman HF, Ginzberg SP (1965) Failure of systemic analgesic agents to alter the absolute sensory threshold for the simple detection of pain. Brain 88:1011–1022 Chen XJ, Gallar J, Pozo MA, Baeza M, Belmonte C (1995) CO2 stimulation of the cornea: a comparison between human sensation and nerve activity in polymodal nociceptive afferents of the cat. Eur J NeuroSci 7:1154–1163 Chizh BA, Gohring M, Troster A, Quartey GK, Schmelz M, Koppert W (2007a) Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth 98:246–254 Chizh BA, O’Donnell MB, Napolitano A, Wang J, Brooke AC, Aylott MC, Bullman JN, Gray EJ, Lai RY, Williams PM, Appleby JM (2007) The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132:132–141 Devor M, Seltzer Z (1999) Pathophysiology of injured nerve. In: Wall PD, Melzack R (eds) Textbook of pain. Churchill Livingstone, Edinburgh, pp 129–164 Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, Lehman KA, Gillen DA, Hokanson JL, Obrien PC (1997) Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat pain threshold in humans. Neurology 48:501–505 Eisenbarth H, Rukwied R, Petersen M, Schmelz M (2004) Sensitization to bradykinin B1 and B2 receptor activation in UV-B irradiated human skin. Pain 110:197–204 Fairweather I, McGlone F, Reilly D, Rukwied R (2004) Controlled dermal cell damage as human in vivo model for localised pain and inflammation. Inflamm Res 53:118–123 Forster C, Magerl W, Beck A, Geisslinger G, Gall T, Brune K, Handwerker HO (1992) Differential effects of dipyrone, ibuprofen, and paracetamol on experimentally induced pain in man. Agents Actions 35:112–121 Gustorff B, Anzenhofer S, Sycha T, Lehr S, Kress HG (2004) The sunburn pain model: the stability of primary and secondary hyperalgesia over 10 hours in a crossover setting. Anesth Analg 98:173–177 Hamilton SG, Warburton J, Bhattacharjee A, Ward J, McMahon SB (2000) ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia. Brain 123:1238–1246 Hoffmann RT, Schmelz M (1999) Time course of UVA- and UVB-induced inflammation and hyperalgesia in human skin. Eur J Pain 3:131–139 Hosogi M, Schmelz M, Miyachi Y, Ikoma A (2006) Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch. Pain 126:16–23 Ikeda H, Heinke B, Ruscheweyh R, Sandkuhler J (2003) Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299:1237–1240 Ikoma A, Fartasch M, Heyer G, Miyachi Y, Handwerker H, Schmelz M (2004) Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology 62:212–217 Kilo S, Schmelz M, Koltzenburg M, Handwerker HO (1994) Different patterns of hyperalgesia induced by experimental inflammations in human skin. Brain 117:385–396 Kilo S, Forster C, Geisslinger G, Brune K, Handwerker HO (1995) Inflammatory models of cutaneous hyperalgesia are sensitive to effects of ibuprofen in man. Pain 62:187–193 Klein T, Magerl W, Hopf HC, Sandkuhler J, Treede RD (2004) Perceptual correlates of nociceptive long-term potentiation and long-term depression in humans. J Neurosci 24:964–971 Klein T, Magerl W, Nickel U, Hopf HC, Sandkuhler J, Treede RD (2007) Effects of the NMDA-receptor antagonist ketamine on perceptual correlates of long-term potentiation within the nociceptive system. Neuropharmacology 52:655–661 Kohlloffel LU, Koltzenburg M, Handwerker HO (1991) A novel technique for the evaluation of mechanical pain and hyperalgesia. Pain 46:81–87 Koltzenburg M, Torebjörk HE, Wahren LK (1994) Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 117:579–591 Koppert W, Dern SK, Sittl R, Albrecht S, Schuttler J, Schmelz M (2001) A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology 95:395–402 Koppert W, Brueckl V, Weidner C, Schmelz M (2004) Mechanically induced axon reflex and hyperalgesia in human UV-B burn are reduced by systemic lidocaine. Eur J Pain 8:237–244 Lotsch J, Angst MS (2003) The μ-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: a pharmacological evaluation of the freeze lesion in humans. Pain 102:151–161 Miller CC, Hale P, Pentland AP (1994) Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway, Evidence for UVB-induced epidermal growth factor receptor activation. J Biol Chem 269:3529–3533 Mohammadian P, Hummel T, Loetsch J, Kobal G (1997) Bilateral hyperalgesia to chemical stimulation of the nasal mucosa following unilateral inflammation. Pain 73:407–412 Moiniche S, Dahl JB, Kehlet H (1993) Time course of primary and secondary hyperalgesia after heat injury to the skin. Br J Anaesth 71:201–205 Ochoa JL, Yarnitsky D (1993) Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann Neurol 33:465–472 Pedersen JL, Kehlet H (1998) Secondary hyperalgesia to heat stimuli after burn injury in man. Pain 76:377–384 Petersen KL, Rowbotham MC (1999) A new human experimental pain model: the heat/capsaicin sensitization model. NeuroReport 10:1511–1516 Petersen K, Schmelz M (2008) Human pain models: virtues and limitations. In: Castro-Lopez J, Raja SN, Schmelz M (eds) Pain 2008. An updated review. IASP Press, Seattle, pp 77–88 Petersen KL, Fields HL, Brennum J, Sandroni P, Rowbotham MC (2000) Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 88:125–133 Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Botefur IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihofner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B (2006) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123:231–243 Rukwied R, Meyer A, Schley M, Kluschina O, Schmelz M (2008) Nerve growth factor causes sustained nociceptor sensitization in human skin. Soc Neurosci Abstr 38:267.14 Sandkuhler J (2009) Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89:707–758 Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE (1997) Differential sensitivity of mechanosensitive and -insensitive C-fibers in human skin to tonic pressure and capsaicin. Soc Neurosci Abstr 23(part 1):1004 Schmelz M, Schmidt R, Handwerker HO, Torebjörk HE (2000) Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres. Brain 123:560–571 Schmidt R, Schmelz M, Torebjörk HE, Handwerker HO (2000) Mechano-insensitive nociceptors encode pain evoked by tonic pressure to human skin. Neurosci 98:793–800 Simone DA, Ngeow JVF, LaMotte RH (1985) Neurogenic spread of hyperalgesia after intracutaneous injection of capsaicin in human subjects. Soc Neurosci Abstr 11:123 Simone DA, Baumann TK, LaMotte RH (1989) Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 38:99–107 Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE (2006) Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 128:509–522 Tegeder I, Meier S, Burian M, Schmidt H, Geisslinger G, Lotsch J (2003) Peripheral opioid analgesia in experimental human pain models. Brain 126:1092–1102 Troster A, Sittl R, Singler B, Schmelz M, Schuttler J, Koppert W (2006) Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology 105:1016–1023 Wasner G, Schattschneider J, Binder A, Baron R (2004) Topical menthol—a human model for cold pain by activation and sensitization of C nociceptors. Brain 127:1159–1171 Zhuang ZY, Xu H, Clapham DE, Ji RR (2004) Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24:8300–8309